Literature DB >> 2426139

Involvement of the Ca2+-dependent K+ channel activity in the hyperpolarizing response induced by epidermal growth factor in mammary epithelial cells.

K Enomoto, M F Cossu, T Maeno, C Edwards, T Oka.   

Abstract

Epidermal growth factor (EGF) induces a hyperpolarizing response of 5-20 mV amplitude in mouse mammary epithelial cells in culture. The amplitude of the hyperpolarizing response was reduced by more than 60% within several minutes after addition of blockers of voltage and/or Ca2+-dependent K+ channels such as tetraethylammonium (7 mM) or quinine (0.29 mM). Both nifedipine (0.15 mM), a blocker of the Ca2+ channel, and ruthenium red (2 mM), an inhibitor of the Ca2+-binding site, also reduced the amplitude of the hyperpolarizing response by more than 60%. The Ca2+ ionophore, A23187 (3.8 microM), induced a large hyperpolarization, which was 25-40 mV and lasted about 3 min. These data suggest that activity of the Ca2+-dependent K+ channel was involved in the EGF-induced hyperpolarizing response of the mammary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426139     DOI: 10.1016/0014-5793(86)80738-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Single calcium-activated potassium channel in cultured mammary epithelial cells.

Authors:  K Furuya; K Enomoto; S Furuya; S Yamagishi; C Edwards; T Oka
Journal:  Pflugers Arch       Date:  1989-06       Impact factor: 3.657

2.  A 23-pS Ca2(+)-activated K+ channel in MCF-7 human breast carcinoma cells: an apparent correlation of channel incidence with the rate of cell proliferation.

Authors:  E A Wegman; J A Young; D I Cook
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

3.  Epidermal growth factor-urogastrone causes vasodilatation in the anesthetized dog.

Authors:  B S Gan; K L MacCannell; M D Hollenberg
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

4.  Oscillating activity of a calcium-activated K+ channel in normal and cancerous mammary cells in culture.

Authors:  K Enomoto; K Furuya; T Maeno; C Edwards; T Oka
Journal:  J Membr Biol       Date:  1991-01       Impact factor: 1.843

5.  Spontaneous calcium oscillations and mechanically and chemically induced calcium responses in mammary epithelial cells.

Authors:  K Furuya; K Enomoto; S Yamagishi
Journal:  Pflugers Arch       Date:  1993-01       Impact factor: 3.657

Review 6.  Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle.

Authors:  Douglas J Blackiston; Kelly A McLaughlin; Michael Levin
Journal:  Cell Cycle       Date:  2009-11-24       Impact factor: 4.534

7.  Physiological epidermal growth factor concentrations activate high affinity receptors to elicit calcium oscillations.

Authors:  Béatrice Marquèze-Pouey; Sébastien Mailfert; Vincent Rouger; Jean-Marc Goaillard; Didier Marguet
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

8.  SK3/TRPC1/Orai1 complex regulates SOCE-dependent colon cancer cell migration: a novel opportunity to modulate anti-EGFR mAb action by the alkyl-lipid Ohmline.

Authors:  Maxime Guéguinou; Thomas Harnois; David Crottes; Arnaud Uguen; Nadine Deliot; Audrey Gambade; Aurélie Chantôme; Jean Pierre Haelters; Paul Alain Jaffrès; Marie Lise Jourdan; Günther Weber; Olivier Soriani; Philippe Bougnoux; Olivier Mignen; Nicolas Bourmeyster; Bruno Constantin; Thierry Lecomte; Christophe Vandier; Marie Potier-Cartereau
Journal:  Oncotarget       Date:  2016-06-14

9.  Ion channels expression and function are strongly modified in solid tumors and vascular malformations.

Authors:  Antonella Biasiotta; Daniela D'Arcangelo; Francesca Passarelli; Ezio Maria Nicodemi; Antonio Facchiano
Journal:  J Transl Med       Date:  2016-10-04       Impact factor: 5.531

Review 10.  Growth control and differentiation in mammary epithelial cells.

Authors:  F Borellini; T Oka
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.